Hormonal contraception in Chinese men: Variations in suppression of spermatogenesis with injectable testosterone undecanoate and levonorgestrel implants

Asian Journal of Andrology

Volumn 6, Issue 1, 2004, Pages 41-46

  Liu, Si Tian ^a   Gui, You Lun ^b   Lin, Cui Hong ^b   He, Chang Hai ^b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF PLANNED PARENTHOOD RESEARCH   (China)

Author keywords

Hormonal contraception; Levonorgestrel; Spermatogenesis; Testosterone undecanocate

Indexed keywords

FOLLITROPIN; LEVONORGESTREL; LUTEINIZING HORMONE; STEROID; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

ADULT; ARTICLE; AZOOSPERMIA; CELL FUNCTION; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; DRUG IMPLANT; FOLLITROPIN BLOOD LEVEL; HORMONAL CONTRACEPTION; HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS TESTIS SYSTEM; INJECTION; LEYDIG CELL; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MALE GENITAL TRACT PARAMETERS; OLIGOSPERMIA; SEMINAL PLASMA; SPERMATOGENESIS; SPERMATOZOON COUNT; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL; VOLUNTEER;

ADULT; CONTRACEPTIVE AGENTS, MALE; DRUG IMPLANTS; FOLLICLE STIMULATING HORMONE; HUMANS; INJECTIONS; LEVONORGESTREL; LEYDIG CELLS; LUTEINIZING HORMONE; MALE; SPERM COUNT; SPERMATOGENESIS; TESTOSTERONE;

EID: 1842483372     PISSN: 1008682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Anderson RA, Baird DT. Male contraception. Endocr Rev 2002; 23: 735-62.
2. Waites GMH. Development of methods of male contraception: impact of the World Health Organization Task Force. Fertil Steril 2003; 80: 1-15.
3. Sokal DC.Recent research on vasectomy techniques. Asian J Androl 2003; 5: 227-30.
4. Reddy PR.Hormonal contraception for human males: prospects. Asian J Androl 2000; 2: 46-50.
5. Shearer SB, Alvarez-Sanchez F, Anselmo J. Hormonal contraception for men. Int J Androl 1978 (Suppl); 12: 680-710.
6. Zhang GY, Gu YQ, Wang XH, Cui YG, Bremner WJ. A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men. J Clin Endocrinol Metab 1999; 84: 3642-7.
7. Gao ES, Lin CH, Gui YL, Li LM, He CH. Inhibitine effects of sino-implant plus testosterone undecanoate (TU) on spermatogenesis in Chinese men. Shengzhi Yu Biyun 1999; 19: 98-105.
8. He CH, Lin CH, Bremner Wj, Gui YL, Gao ES. Effects of Sino-implant with testosterone undecanoate(TU) on the pituitary axis in Chinese men. Shengzhi Yu Biyun (In Chinese) 2001; 21: 86-91.
9. Wallace EM, Gow SM, Wu FC. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations. J Clin Endocrinol Metab 1993; 77: 290-3.
10. Anderson RA, Wu FC. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once weekly administration of testosterone enanthate. J Clin Endocrinol Metab 1996; 81: 896-901.
11. World Health Organization. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction (3rd edition). Cambridge: Cambridge University Press; 1992.
12. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 1990; 336: 955-9.
13. World Health Organization Task Forced on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 1996; 65: 821-9.
14. Lookingbill DP, Demers LM, Wang C, Leung A, Rittmaster RS, Santen RJ. Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects. J Clin Endocrinol Metab 1991; 72: 1242-8.
15. McLachlan RI, McDonald J, Rushford D, Robertson DM, Garrett C, Baker HW. Efficacy and acceptability of testosterone implants, alone or in combination with a 5alpha-reductase inhibitor, for male hormonal contraception. Contraception 2000; 62: 73-8.
16. Wang C, Chan SY, Leung A, Ng RP, Ng M, Tang LC. Cross-sectional study of semen parameters in a large group of normal Chinese men. Int J Androl 1985; 8: 257-4.
17. Sivin I, Lahteenmaki P, Ranta S, Darney P, Klaisle C, Wan L, et al. Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants. Contraception 1997; 55: 81-5.
18. Wu SL, Yang DA. Effect on ovarian and pituitary hormones by Sino-implant. Zhongguo Ji Hua Sheng Yu Za Zhi (in Chinese) 1993; 5: 267.
19. Behre HM, Baus S, Kliesch S, Keck C, Simoni M, Nieschlag E. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders. J Clin Endocrinol Metab 1995; 80: 2394-403.
20. Weinbauer GF, Schlatt S, Walter V, Nieschlag N. Testosterone-induced inhibition of spermatogenesis is more closely related to suppression of FSH than to testicular androgen levels in the cynomolgus monkey model (Macaca fascicularis). J Endocrinol 2001; 168: 25-38.